Enveric Current Deferred Revenue from 2010 to 2026
| ENVB Stock | USD 2.02 0.09 4.27% |
Current Deferred Revenue | First Reported 1999-03-31 | Previous Quarter -1 M | Current Value 1.5 M | Quarterly Volatility 3 B |
Check Enveric Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enveric Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 572.8 K, Interest Expense of 3.2 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 4.91, Dividend Yield of 31.8 K or PTB Ratio of 1.86. Enveric financial statements analysis is a perfect complement when working with Enveric Biosciences Valuation or Volatility modules.
Enveric | Current Deferred Revenue | Build AI portfolio with Enveric Stock |
Analyzing Enveric Biosciences's Current Deferred Revenue over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Current Deferred Revenue has evolved provides context for assessing Enveric Biosciences's current valuation and future prospects.
Latest Enveric Biosciences' Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Enveric Biosciences over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Enveric Biosciences' Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Enveric Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Enveric Current Deferred Revenue Regression Statistics
| Arithmetic Mean | (1,593,961) | |
| Coefficient Of Variation | (82.00) | |
| Mean Deviation | 1,205,052 | |
| Median | (2,582,661) | |
| Standard Deviation | 1,307,073 | |
| Sample Variance | 1.7T | |
| Range | 3M | |
| R-Value | (0.81) | |
| Mean Square Error | 636.6B | |
| R-Squared | 0.65 | |
| Significance | 0.000092 | |
| Slope | (208,786) | |
| Total Sum of Squares | 27.3T |
Enveric Current Deferred Revenue History
About Enveric Biosciences Financial Statements
Enveric Biosciences stakeholders use historical fundamental indicators, such as Enveric Biosciences' Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Enveric Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Enveric Biosciences' assets and liabilities are reflected in the revenues and expenses on Enveric Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Enveric Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -2.3 M | -2.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Enveric Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enveric Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enveric Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enveric Biosciences Stock:Check out the analysis of Enveric Biosciences Correlation against competitors. For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enveric Biosciences. Projected growth potential of Enveric fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Enveric Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (119.64) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
Understanding Enveric Biosciences requires distinguishing between market price and book value, where the latter reflects Enveric's accounting equity. The concept of intrinsic value - what Enveric Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Enveric Biosciences' price substantially above or below its fundamental value.
It's important to distinguish between Enveric Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Enveric Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Enveric Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.